Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813208) titled 'Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival' on Sept. 2.
Study Type: Observational
Primary Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Condition:
Acute Lymphoblastic Leukemia, Pediatric
Recruitment Status: Recruiting
Date of First Enrollment: August 1, 2025
Target Sample Size: 500
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07813208
Disclaimer: Curated by HT Syndication....